Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.8.0.1
Consolidated Balance Sheets
$ in Thousands, € in Millions
Dec. 31, 2017
USD ($)
Dec. 31, 2016
USD ($)
Current assets    
Cash and cash equivalents $ 113,915 $ 88,294
Accounts receivable 7,758 1,830
Short-term investments (certificates of deposit) 36,002 0
Cash deposits with clearing organizations 1,041 1,030
Receivables from broker-dealers and clearing organizations 7,395 3,357
Forgivable loans receivable 1,616 1,712
Securities owned, at fair value 1,985 2,357
Inventory 171 203
Other receivables - related party 618 1,790
Prepaid expenses and other current assets 12,680 9,061
Total current assets 183,181 109,634
Property and equipment, net 9,513 7,376
Restricted cash 17,387 15,860
Long-term investments, at fair value 1,390 1,414
Intangible assets 15,223 17,408
Goodwill 18,645 18,645
Other assets 611 394
Total assets 245,950 170,731
Current liabilities    
Accounts payable and accrued expenses 36,127 24,295
Accounts payable and accrued expenses - related party 222 0
Accrued commissions and payroll payable 10,065 11,940
Deferred clearing and marketing credits 786 995
Securities sold, not yet purchased, at fair value 151 298
Warrants issued in 2017 and issuable in 2016 - National 5,597 14,359
Interest payable 315 88
Interest payable - related party 669 77
Notes payable, short-term (net of debt discount of $973 and $0 at December 31, 2017 and December 31, 2016, respectively) 8,528 1,000
Subsidiary convertible note, short-term, at fair value 4,700 1,031
Contingently issuable liabilities 0 1,682
Derivative warrant liability 87 481
Other current liabilities 181 319
Total current liabilities 67,428 56,565
Notes payable, long-term (net of debt discount of $62 and $2,009 at December 31, 2017 and December 31, 2016, respectively) 43,222 22,528
Subsidiary convertible note, long-term, at fair value 10,059 3,656
Other long-term liabilities 4,739 5,014
Total liabilities 125,448 87,763
Commitments and contingencies
Stockholders' equity    
Preferred stock, $.001 par value, 15,000,000 authorized, 5,000,000 designated Series A shares 1,000,000 and 0 shares issued and outstanding as of December 31, 2017 and December 31, 2016, respectively 1 0
Common Stock, $.001 par value, 100,000,000 shares authorized, 50,991,285 and 48,932,023 shares issued and outstanding as of December 31, 2017 and December 31, 2016, respectively 51 49
Common stock issuable, 158,015 and 0 shares as of December 31, 2017 and December 31, 2016, respectively 500 0
Additional paid-in-capital 364,148 283,697
Accumulated deficit (312,127) (245,251)
Total stockholders' equity attributed to the Company 52,573 38,495
Non-controlling interests 67,929 44,473
Total stockholders' equity 120,502 82,968
Total liabilities and stockholders' equity $ 245,950 $ 170,731